Ana Rilak Simovic

3PUBLICATIONS
4CO-AUTHORS
Main group metal chemistryCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 13, 2021
A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug: in vitro and in vivo activity in murine colon cancer.

Dejan Lazić, Andreas Scheurer, Dušan Ćoćić

|Oct 17, 2020
Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.

Maja Savic, Aleksandar Arsenijevic, Jelena Milovanovic

Pageof 1